Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fulminant hepatic failure.

D J Hetzel

    Anaesthesia and Intensive Care
    |August 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Fulminant hepatic failure (FHF) is a severe liver condition often caused by viral hepatitis or drug toxicity. While management is supportive, novel temporary hepatic support systems show promise for potentially reversible liver lesions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Direct and correlated responses to selection for post-weaning weight gain on ad libitum or restricted feeding in mice.

    TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
    Same author

    Clinical audit: recent practice in caring for patients with acute severe colitis compared with published guidelines--is there a problem?

    Internal medicine journal·2012
    Same author

    Potentially avoidable surgery in inflammatory bowel disease: what proportion of patients come to resection without optimal preoperative therapy? A guidelines-based audit.

    Internal medicine journal·2010
    Same author

    Genetic diversity of Asian water buffalo (Bubalus bubalis): mitochondrial DNA D-loop and cytochrome b sequence variation.

    Animal genetics·1998
    Same author

    New markers on bovine chromosome 1 are closely linked to the polled gene in Simmental and Pinzgauer cattle.

    Mammalian genome : official journal of the International Mammalian Genome Society·1997
    Same author

    Genetic diversity of Asian water buffalo (Bubalus bubalis): microsatellite variation and a comparison with protein-coding loci.

    Animal genetics·1997
    Same journal

    A brief history of colour in the operating theatre.

    Anaesthesia and intensive care·2026
    Same journal

    Evaluating the completeness of perioperative outcome metrics in electronic medical records: Insights based on the proposed Perioperative Clinical Outcomes Registry framework.

    Anaesthesia and intensive care·2026
    Same journal

    Large language model prompt engineering for medical education: A practical guide for the Australian and New Zealand College of Anaesthetists Final Examination.

    Anaesthesia and intensive care·2026
    Same journal

    Nitrous oxide added at the end of sevoflurane anaesthesia hastens emergence and eliminates prolonged time to extubation (SEVONATE study): A randomised controlled trial.

    Anaesthesia and intensive care·2026
    Same journal

    Complications related to arterial line catheters and monitoring reported to webAIRS, 2009-2023.

    Anaesthesia and intensive care·2026
    Same journal

    A summary guide for detecting and reducing nitrous oxide infrastructure leaks in healthcare facilities.

    Anaesthesia and intensive care·2026
    See all related articles

    Area of Science:

    • Hepatology
    • Critical Care Medicine
    • Transplant Surgery

    Background:

    • Fulminant hepatic failure (FHF) is a rare, life-threatening condition characterized by rapid, extensive liver necrosis.
    • Patients, often young and previously healthy, experience profound illness with coma and severe metabolic disturbances.
    • High mortality rates necessitate exploring advanced treatment strategies beyond supportive care.

    Purpose of the Study:

    • To review the current understanding and management of fulminant hepatic failure (FHF).
    • To explore the potential of temporary hepatic support systems for patients with potentially reversible liver injury.
    • To evaluate the reported efficacy of novel techniques like charcoal column hemoperfusion.

    Main Methods:

    • Review of existing literature on fulminant hepatic failure (FHF) and its management.

    Related Experiment Videos

  • Analysis of historical and emerging temporary hepatic support technologies.
  • Assessment of preliminary data on charcoal column hemoperfusion efficacy.

    • Main Results:

    • FHF is associated with extensive hepatic necrosis, coma, and severe dysfunction of liver synthetic, metabolic, and excretory functions.
    • Management is primarily supportive, often requiring intensive care unit resources for multisystem complications.
    • Various temporary hepatic support techniques have been attempted, with limited confirmed success.

    Conclusions:

    • Fulminant hepatic failure (FHF) remains a critical illness with high mortality, demanding intensive supportive care.
    • The potential reversibility of hepatic lesions fuels interest in temporary hepatic support systems.
    • Charcoal column hemoperfusion shows promise but requires confirmation through controlled clinical trials.